HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland.
about
Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV typesEstimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact.Detection and genotyping of human papillomavirus in urine samples from unvaccinated male and female adolescents in Italy.Higher prevalence of human papillomavirus infection in adolescent and young adult girls belonging to different Indian tribes with varied socio-sexual lifestyle.Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in ScotlandMonitoring human papillomavirus prevalence in urine samples: a review.Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis.The Impact of Adjustment for Socioeconomic Status on Comparisons of Cancer Incidence between Two European Countries.Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.Achieving high and equitable coverage of adolescent HPV vaccine in Scotland.HPV persistence and its oncogenic role in prostate tumors.Use of HPV testing for cervical screening in vaccinated women--Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study.Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment.HPV prevalence and type distribution in women with normal or abnormal Pap smear in Bulgaria.Human papillomavirus infection among young adolescents in India: impact of vaccination.Options for design of real-world impact studies of single-dose vaccine schedules
P2860
Q33682928-CB2F194C-6C8B-4EE9-A99B-70318F419521Q34493286-1C92D328-54AD-48D9-99B8-6985D81AF1E1Q35047423-8A64357C-5DC1-4259-A50F-885FF4F2B3F7Q35587663-3F197EA1-E684-4E2C-A2E0-5E046CB304D8Q35678090-94C878E2-45F8-4071-B953-BD4B03E7D1BDQ36694308-D1A1C9CD-D99D-4174-BA42-834890F85EB5Q36964366-10D7E28A-D2EB-451B-8BAB-FDE7887F9ED0Q37436752-6E0E477A-92BE-4BBD-B99A-183948B59425Q38893196-6922CE6D-9D4E-4335-A8E3-D272E20EBDE2Q39359552-D63E3776-CC32-4913-9C44-3A2794B9690CQ40059724-487F1347-6E50-4F5E-B70C-8C4B109A4C78Q40805660-5FE1854C-6ECE-48F4-AD8B-E736D201889AQ41330441-E8BA85CA-7B1D-4BD3-A306-579CA30BDF46Q42203937-B87402C9-1782-4314-90B2-8AD6ECEB85BEQ45392523-4E59E702-37C5-4A3B-BB10-4B2097702CD2Q58279434-DC8EC126-4FBC-4988-8F07-9DCF3FF557C4
P2860
HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HPV type-specific prevalence u ...... - to 18-year olds in Scotland.
@ast
HPV type-specific prevalence u ...... - to 18-year olds in Scotland.
@en
HPV type-specific prevalence u ...... - to 18-year olds in Scotland.
@nl
type
label
HPV type-specific prevalence u ...... - to 18-year olds in Scotland.
@ast
HPV type-specific prevalence u ...... - to 18-year olds in Scotland.
@en
HPV type-specific prevalence u ...... - to 18-year olds in Scotland.
@nl
prefLabel
HPV type-specific prevalence u ...... - to 18-year olds in Scotland.
@ast
HPV type-specific prevalence u ...... - to 18-year olds in Scotland.
@en
HPV type-specific prevalence u ...... - to 18-year olds in Scotland.
@nl
P2093
P2860
P356
P1476
HPV type-specific prevalence u ...... - to 18-year olds in Scotland.
@en
P2093
C Robertson
K Cuschieri
M C O'Leary
P2860
P2888
P304
P356
10.1038/BJC.2011.30
P407
P577
2011-02-22T00:00:00Z
P5875
P6179
1048807718